ProQR Therapeutics N.V.

NASDAQ:PRQR

Biotechnology

Healthcare
$1.10 +12.28%

+$0.21 today

Market cap
$155.23M
Beta
0.06
P/E (TTM)
-3.8
EPS (TTM)
-$0.43
52W Low $1.33High $3.10

Volume 0.88M

Average 0.62M

PRQR Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

ProQR Therapeutics N.V.NASDAQ: PRQR

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 65.9%

Gross margin was 65.9% in Q1 FY2026, down 34.1 pp from a year earlier. On a trailing-twelve-month basis it was 89.7%, down 10.3 pp year over year. Over 3 fiscal years it narrowed by 17.0 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
65.9%-19.7 pp QoQ
Last fiscal yearDec 2025
83.0%-17.0 pp YoY
LTMMar 2026
89.7%-10.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-34.1 pp——
1 year-17.0 pp——
3 years-17.0 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
83.0%
Year-over-year change
-17.0pp

Gross Margin vs competitors

How PRQR compares with its peers on the latest reported figures

  • PRQR's LTM Mar 2026 gross margin of 89.7% is the 3rd highest of the 7 companies compared; the peer median is -50.0%.
  • Its year-over-year change of -10.3 pp is the 4th highest of 6, against a peer median of -8.8 pp.
  • Over three fiscal years its change of -17.0 pp compares with a peer median of -0.5 pp.
PRQR Competitors Peer median
Gross Margin for PRQR and competitors
Company Period LTM level YoY 3-year change
VNDAVanda Pharmaceuticals Inc.LTM Mar 202692.5% -1.0 pp+3.5 pp
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 202691.2% -8.8 pp-4.5 pp
PRQRProQR Therapeutics N.V.LTM Mar 202689.7% -10.3 pp-17.0 pp
EDITEditas Medicine, Inc.LTM Mar 20265.8% +124.1 pp+32.1 pp
MREOMereo BioPharma Group plcLTM Mar 2026-105.7% ——
TRDAEntrada Therapeutics, Inc.LTM Mar 2026-598.0% -698.0 pp—
IMMPImmutep LimitedFY2025-1117.6% -136.1 pp-6.4 pp
ACHVAchieve Life Sciences, Inc.FY2025— ——
CAPRCapricor Therapeutics, Inc.FY2025— ——
ALLOAllogene Therapeutics, Inc.FY2025— ——
ZURAZura Bio LimitedFY2025— ——
Peer median (excluding PRQR) -50.0%-8.8 pp-0.5 pp

Competitors are the stored peer set for PRQR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.34M3.59M6.51M18.91M15.28M
Cost of Revenue00002.6M
Gross Profit1.34M3.59M6.51M18.91M12.68M
Gross Margin100.0%100.0%100.0%100.0%83.0%
Research & Development42.22M50.87M25.15M36.36M40.72M
Selling, General & Admin17.37M18.65M16.24M13.66M14.12M
Operating Expenses58.55M68.75M38.37M49.38M54.84M
Depreciation & Amortization2.33M2.52M2.51M2.76M2.6M
EBITDA(54.95M)(56.46M)(24.1M)(24.12M)(37.04M)
EBITDA Margin-4116.0%-1571.0%-369.9%-127.6%-242.4%
Operating Income(57.21M)(65.16M)(31.86M)(30.47M)(42.15M)
Operating Margin-4285.4%-1813.0%-489.1%-161.2%-275.9%
Interest Income5K106K2.59M3.25M2.24M
Interest Expense3.41M5.13M1.2M1.08M866.4K
Other Income / Expenses(3.47M)1.05M4.05M2.51M1.65M
Income Before Tax(60.68M)(64.11M)(27.81M)(27.96M)(40.5M)
Pre-Tax Margin-4545.5%-1783.8%-427.0%-147.9%-265.1%
Income Tax Expense117K96K(78K)(197K)18.25K
Net Income(60.74M)(64.42M)(28.12M)(27.76M)(40.52M)
Net Margin-4549.8%-1792.5%-431.7%-146.9%-265.2%
EPS (Basic)(0.96)(0.91)(0.35)(0.34)(0.38)
EPS (Diluted)(0.96)(0.91)(0.35)(0.34)(0.38)
Weighted Avg Shares64.18M71.64M81.01M81.67M105.33M
Weighted Avg Shares (Diluted)64.18M71.64M81.01M81.67M105.33M

ProQR Therapeutics N.V.

NASDAQ:PRQR

Intrinsic Alpha fair value

Locked

Current Price

$1.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.